The Food and Drug Administration is reviewing a new antibody drug for COVID-19 that could significantly improve protection for people at the highest risk: those with compromised immune systems.
FDA weighs new COVID antibody drug that could be 'holy grail' for immunocompromised
Credit: ABC 10 News | San Diego
Duration: 03:00s
0 shares
1 views